Andromeda-Shock 2

Revolutionizing resuscitation in Septic Shock!

References

  1. Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR, et al. Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the Global Burden of Disease Study. Lancet. 2020;395:200–11.

  2. Boyd JH, Forbes J, Nakada TA, Walley KR, Russell JA, Frcp C, et al. Fluid resuscitation in septic shock: A positive fluid balance and elevated central venous pressure are associated with increased mortality. Crit Care Med. 2011;39:259–65.

  3. Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Intensive Care Med. 2017;43:304–77.

  4. Cecconi M, Evans L, Levy M, Rhodes A. Sepsis and septic shock. Lancet. 2018;392:75–87.

  5. Hernandez G, Ospina-Tascon G, Damiani LP, Estenssoro E, Dubin A, Hurtado J, et al. Effect of a Resuscitation Strategy Targeting Peripheral Perfusion Status vs Serum Lactate Levels on 28- Day Mortality Among Patients With Septic Shock. The ANDROMEDA-SHOCK Randomized Clinical Trial. JAMA. 2019;321:654–64.

  6. Permpikul C, Tongyoo S, Viarasilpa T, Trainarongsakul T, Chakorn T, Udompanturak S. Early Use of Norepinephrine in Septic Shock Resuscitation (CENSER). A Randomized Trial. Am J Respir Crit Care Med [Internet]. 2019 [cited 2019 Nov 7];199:1097–105. Available from: https://www.atsjournals.org/doi/10.1164/rccm.201806-1034OC

  7. Ospina-Tascón GA, Hernandez G, Alvarez I, Calderón-Tapia LE, Manzano-Nunez R, Sánchez-Ortiz AI, et al. Effects of very early start of norepinephrine in patients with septic shock: A propensity score-based analysis. Crit Care [Internet]. BioMed Central Ltd.; 2020 [cited 2021 May 12];24:1–11. Available from: https://doi.org/10.1186/s13054-020-2756-3

  8. Geri G, Vignon P, Aubry A, Fedou A-L, Charron C, Silva S, et al. Cardiovascular clusters in septic shock combining clinical and echocardiographic parameters: a post hoc analysis. Intensive Care Med [Internet]. 2019;45:657–67. Available from: http://link.springer.com/10.1007/s00134-019-05596-z

  9. Seymour CW, Kennedy JN, Wang S, Chang CH, Elliott CF, Xu Z, et al. Derivation, Validation, and Potential Treatment Implications of Novel Clinical Phenotypes for Sepsis. 2019;15261.

  10. Hernández G, Kattan E, Tascón GO, Bakker J, The RC. Capillary refill time status could identify different clinical phenotypes among septic shock patients fulfilling Sepsis ‑ 3 criteria : a post hoc analysis of ANDROMEDA ‑ SHOCK trial. Intensive Care Med [Internet]. 2020;4–6. Available from: https://doi.org/10.1007/s00134-020-05960-4

  11. Hariri G, Joffre J, Leblanc G, Bonsey M, Lavillegrand J-R, Urbina T, et al. Narrative review: clinical assessment of peripheral tissue perfusion in septic shock. Ann Intensive Care [Internet]. 2019 [cited 2020 Jan 21];9:37. Available from: https://annalsofintensivecare.springeropen.com/articles/10.1186/s13613-019-0511-1

  12. Ait-Oufella H, Lemoinne S, Boelle PY, Galbois A, Baudel JL, Lemant J, et al. Mottling score predicts survival in septic shock. Intensive Care Med. 2011;37:801–7.

  13. Lara B, Enberg L, Ortega M, Leon P, Kripper C, Aguilera P, et al. Capillary refill time during fluid resuscitation in patients with sepsis-related hyperlactatemia at the emergency department is related to mortality. PLoS One. 2017;12:e0188548.

  14. Hernandez G, Pedreros C, Veas E, Bruhn A, Romero C, Rovegno M, et al. Evolution of peripheral vs metabolic perfusion parameters during septic shock resuscitation. A clinical- physiologic study. J Crit Care. 2012;27:283–8.

  15. Alegría L, Vera M, Dreyse J, Castro R, Carpio D, Henriquez C, et al. A hypoperfusion context may aid to interpret hyperlactatemia in sepsis-3 septic shock patients: a proof-of-concept study. Ann Intensive Care. 2017;7:29.

  16. Brunauer A, Koköfer A, Bataar O, Gradwohl-Matis I, Dankl D, Bakker J, et al. Changes in peripheral perfusion relate to visceral organ perfusion in early septic shock: A pilot study. J Crit Care. 2016;35:105–9.

  17. Zampieri FG, Damiani LP, Bakker J, Ospina-Tascón GA, Castro R, Cavalcanti AB, et al. Effect of a Resuscitation Strategy Targeting Peripheral Perfusion Status vs Serum Lactate Levels on 28-Day Mortality Among Patients with Septic Shock: A Bayesian Reanalysis of the ANDROMEDA-SHOCK Trial. Am J Respir Crit Care Med. 2020;201:423–9.

  18. Mekontso Dessap A. Frugal innovation for critical care. Intensive Care Med [Internet]. Springer Berlin Heidelberg; 2019;45:252–4. Available from: https://doi.org/10.1007/s00134-018-5391-6

  19. Castro R, Kattan E, Ferri G, Pairumani R, Valenzuela ED, Alegría L, et al. Effects of capillary refill time ‑ vs . lactate ‑ targeted fluid resuscitation on regional , microcirculatory and hypoxia ‑ related perfusion parameters in septic shock : a randomized controlled trial. Ann Intensive Care [Internet]. Springer International Publishing; 2020; Available from: https://doi.org/10.1186/s13613-020-00767-4

  20. Kattan E, Castro R, Vera M, Hernández G. Optimal target in septic shock resuscitation. Ann Transl Med. 2020;8:789–789.

  21. Varpula M, Tallgren M, Saukkonen K, Voipio-Pulkki LM, Pettilä V. Hemodynamic variables related to outcome in septic shock. Intensive Care Med. 2005;31:1066–71.

  22. Maheshwari K, Nathanson BH, Munson SH, Khangulov V, Stevens M, Badani H, et al. The relationship between ICU hypotension and in ‑ hospital mortality and morbidity in septic patients. Intensive Care Med [Internet]. Springer Berlin Heidelberg; 2018;44:857–67. Available from: https://doi.org/10.1007/s00134-018-5218-5

  23. Kattan E, Ospina-Tascón GA, Teboul JL, Castro R, Cecconi M, Ferri G, et al. Systematic assessment of fluid responsiveness during early septic shock resuscitation: Secondary analysis of the ANDROMEDA-SHOCK trial. Crit Care. 2020;24:23.

  24. Ospina-Tascón GA, Hernandez G, Alvarez I, Calderón-tapia LE, Manzano-nunez R, Sánchez-ortiz AI, et al. Effects of very early start of norepinephrine in patients with septic shock : a propensity score-based analysis. Crit Care. 2020;24:52.

  25. Vincent JL. The coming era of precision medicine for intensive care. Crit Care. 2017;21:1–4.

  26. Mercado P, Maizel J, Beyls C, Titeca-Beauport D, Joris M, Kontar L, et al. Transthoracic echocardiography: An accurate and precise method for estimating cardiac output in the critically ill patient. Crit Care. Critical Care; 2017;21:1–8.

  27. Yang Y, Royse C, Royse A, Williams K, Canty D. Survey of the training and use of echocardiography and lung ultrasound in Australasian intensive care units. Crit Care [Internet]. Critical Care; 2016;20:9–10. Available from: http://dx.doi.org/10.1186/s13054-016-1444-9

  28. Haniffa R, Pubudu De Silva A, de Azevedo L, Baranage D, Rashan A, Baelani I, et al. Improving ICU services in resource-limited settings: Perceptions of ICU workers from low-middle-, and high-income countries. J Crit Care [Internet]. Elsevier Inc; 2018;44:352–6. Available from: https://doi.org/10.1016/j.jcrc.2017.12.007

  29. Rosen I, White H. The relation of Pulse Pressure to Stroke Volume. Am J Physiol. 1926;78:168–84.

  30. Westerhof N, Lankhaar JW, Westerhof BE. The arterial windkessel. Med Biol Eng Comput. 2009;47:131–41.

  31. Wesseling KH, Jansen JRC, Settels JJ, Schreuder JJ. Computation of aortic flow from pressure in humans using a nonlinear, three-element model. J Appl Physiol. 1993;74:2566–73.

  32. Bighamian R, Hahn J. Relationship between Stroke Volume and Pulse Pressure during Blood Volume Perturbation : A Mathematical Analysis. 2014;2014.

  33. Marquez J, McCurry K, Severyn DA, Pinsky MR. Ability of pulse power, esophageal Doppler, and arterial pulse pressure to estimate rapid changes in stroke volume in humans. Crit Care Med. 2008;36:3001–7.

  34. Convertino VA, Cooke WH, Holcomb JB. Arterial pulse pressure and its association with reduced stroke volume during progressive central hypovolemia. J Trauma – Inj Infect Crit Care. 2006;61:629–34.

  35. Ospina-Tascón GA, Teboul JL, Hernandez G, Alvarez I, Sánchez-Ortiz AI, Calderón-Tapia LE, et al. Diastolic shock index and clinical outcomes in patients with septic shock. Ann Intensive Care. 2020;10:41.

  36. Ospina-tascón GA, Hernandez G, Bakker J. Should we start vasopressors very early in septic shock ? 2020;12:3893–6.

  37. Hamzaoui O, Teboul JL. Importance of diastolic arterial pressure in septic shock: PRO. J Crit Care. 2019;51:238–40.

  38. Cinel I, Kasapoglu US, Gul F, Dellinger RP. The initial resuscitation of septic shock. J Crit Care [Internet]. Elsevier Inc.; 2020;57:108–17. Available from: https://doi.org/10.1016/j.jcrc.2020.02.004

  39. Michard F, Teboul J-L. Predicting Fluid Responsiveness in ICU Patients. Chest [Internet]. 2002;121:2000–8. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0012369215350376

  40. Malbrain MLNG, Van Regenmortel N, Saugel B, De Tavernier B, Van Gaal PJ, Joannes-Boyau O, et al. Principles of fluid management and stewardship in septic shock: it is time to consider the four D’s and the four phases of fluid therapy. Ann Intensive Care. 2018;8:66.

  41. Monnet X, Teboul JL. Assessment of fluid responsiveness: Recent advances. Curr Opin Crit Care. 2018;24:190–5.

  42. Kattan E, Ospina-Tascón GA, Teboul J-L, Castro R, Cecconi M, Ferri G, et al. Systematic assessment of fluid responsiveness during early septic shock resuscitation: Secondary analysis of the ANDROMEDA-SHOCK trial. Crit Care. 2020;24.

  43. Cecconi M, Hofer C, Teboul JL, Pettila V, Wilkman E, Molnar Z, et al. Fluid challenges in intensive care: the FENICE study: A global inception cohort study. Intensive Care Med. Springer Berlin Heidelberg; 2015;41:1529–37.

  44. Teboul J, Monnet X. Prediction of volume responsiveness in critically ill patients with spontaneous breathing activity. Curr Opin Crit Care [Internet]. 2008;14:334–9. Available from: http://www.embase.com/search/results?subaction=viewrecord&from=export&id=L3516679 20%0Ahttp://dx.doi.org/10.1097/MCC.0b013e3282fd6e1e

  45. Hernández G, Cavalcanti AB, Ospina-Tascón G, Zampieri FG, Dubin A, Hurtado FJ, et al. Early goal-directed therapy using a physiological holistic view: the ANDROMEDA-SHOCK— a randomized controlled trial. Ann Intensive Care. 2018;8:52.

  46. Monnet X, Marik P, Teboul JL. Passive leg raising for predicting fluid responsiveness: a systematic review and meta-analysis. Intensive Care Med [Internet]. Springer Verlag; 2016 [cited 2021 May 11];42:1935–47. Available from: http://www.prisma-statement.

  47. Vieillard-Baron A, Caille V, Charron C, Belliard G, Page B, Jardin F. Actual incidence of global left ventricular hypokinesia in adult septic shock. Crit Care Med [Internet]. Lippincott Williams and Wilkins; 2008 [cited 2021 May 15];36:1701–6. Available from: https://pubmed.ncbi.nlm.nih.gov/18496368/

  48. Sanfilippo F, Huang S, Herpain A, Balik M, Chew MS, Clau-Terré F, et al. The PRICES statement: an ESICM expert consensus on methodology for conducting and reporting critical care echocardiography research studies. Intensive Care Med [Internet]. Springer Berlin Heidelberg; 2021;47:1–13. Available from: https://doi.org/10.1007/s00134-020-06262-5

  49. Vieillard-Baron A, Millington SJ, Sanfilippo F, Chew M, Diaz-Gomez J, McLean A, et al. A decade of progress in critical care echocardiography: a narrative review. Intensive Care Med [Internet]. Springer Berlin Heidelberg; 2019;45:770–88. Available from: https://doi.org/10.1007/s00134-019-05604-2

  50. Dong G, Qiu J, Wang D, Vandemeulebroecke M. The stratified win ratio. J Biopharm Stat [Internet]. J Biopharm Stat; 2018 [cited 2021 Aug 23];28:778–96.

  51. Pocock SJ, Ariti CA, Collier TJ, Wang D. The win ratio: A new approach to the analysis of composite endpoints in clinical trials based on clinical priorities. Eur Heart J [Internet]. Eur Heart J; 2012;33:176–82.